Article info
Unexpected outcome (positive or negative) including adverse drug reactions
Case report
Adalimumab as a potential cause of drug-induced thrombocytopaenic microangiopathy
- Correspondence to Dr Lorenzo Falsetti; drfalsetti{at}yahoo.it
Citation
Adalimumab as a potential cause of drug-induced thrombocytopaenic microangiopathy
Publication history
- Accepted February 20, 2020
- First published March 4, 2020.
Online issue publication
March 04, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.